Combinatorial targeting of XPO1 and FLT3 exerts synergistic anti-leukemia effects through induction of differentiation and apoptosis in FLT3-mutated acute myeloid leukemias: from concept to clinical trial

Targeted therapies against FLT3-mutated acute myeloid leukemias have shown limited clinical efficacy primarily because of the acquisition of secondary mutations in FLT3 and persistent activation of downstream pro-survival pathways such as MEK/ERK, PI3K/AKT, and STAT5. Activation of these additional...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Weiguo, Ly, Charlie, Ishizawa, Jo, Mu, Hong, Ruvolo, Vivian, Shacham, Sharon, Daver, Naval, Andreeff, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165819/
https://www.ncbi.nlm.nih.gov/pubmed/29773601
http://dx.doi.org/10.3324/haematol.2017.185082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165819/
https://www.ncbi.nlm.nih.gov/pubmed/29773601
http://dx.doi.org/10.3324/haematol.2017.185082

Ejemplares similares